期刊名称：NEUROENDOCRINOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
ISSN 0028-3835
"Neuroendocrinology" publishes papers reporting original research in basic and clinical neuroendocrinology. The journal explores the complex interactions between neuronal networks and endocrine glands (in some instances also immune cells) in both central and peripheral nervous systems. Original contributions cover all aspects of the field, from molecular and cellular neuroendocrinology, physiology, pharmacology, and the neuroanatomy of neuroendocrine systems to neuroendocrine correlates of coping behavior or clinical neuroendocrinology. Readers will also benefit from occasional, well-referenced reviews by noted experts which highlight especially active areas of current research.
Instructions to Authors
Introduction
The Editorial Board of Neuroendocrinology welcomes articles for review that report new observations on interactions between the brain and the endocrine system.
Papers that are published deal with both basic and clinical subjects. Editorials, summaries of meetings, and reviews of timely topics in basic and clinical neuroendocrinology are also published, but these items are accepted only at the invitation of the Editor-in-Chief.
Submission
Manuscripts and all correspondence pertaining to them should be addressed to the Editor-in-Chief:
Dr. Claude Kordon
Institut de Recherches Necker
156 rue de Vaugirard
F?5015 Paris (France)
Fax +33 1 40 61 55 73
E-Mail neuroend@necker.fr
Manuscripts should be written in English. They should contain unpublished results of research work, and should be as concise as possible. They should be typewritten or Letter-quality printed on one side of the paper only and double-spaced with a wide margin. In order to speed up the evaluation process, 5 copies of the manuscript should be submitted, including 5 glossy prints of the figures.
The manuscript should be submitted together with a disk and should match the file on disk exactly. For details refer to Disk Submission. Editorial work and copy-editing will be executed from the disk version of your manuscript.
The following presentation is recommended:
Abstract, Introductory statement on the purpose of the studies, Materials and Methods, Results, Discussion, and References.
Current abbreviations should be used throughout the text and tables:
for pituitary hormones ACTH, beta-END, FSH, GH, LH, TSH
for neuropeptides CRH, not CRF; GAL; GHRH, not GRF; GnRH, not LHRH; NPY; NT; SRIH, not SRIF; VIP etc.
and a definition should be provided the first time each abbreviation appears. Please limit abbreviations to those in common use, and avoid other abbreviations and acronyms.
Manuscripts should contain novel, original data. As a rule, the Editorial office commits itself to achieve initial review of manuscripts within less than 60 days; average interval between submission and publication is 7 months.
Authors of articles reporting mostly confirmatory, fragmentary or preliminary findings may be notified within 2 weeks that their manuscript will not be submitted to formal review. Such a proposal will be made by the associate Editors assisted by one member of the Editorial Board. This procedure is intended to provide rapid feedback to authors of manuscripts which have a poor chance of being accepted. Authors have the opportunity to appeal against the decision.
Contributors should know that one of the criteria considered in reviewing manuscripts is the humane and proper treatment of animals. The editors realize that the use of anesthetics, analgesics, and tranquilizers would defeat the purpose of some experiments. However, the use of painful or otherwise noxious stimuli must be carefully and thoroughly justified in the paper.
Papers that do not meet these criteria will not be accepted for publication.
Rapid Communications
Manuscripts intended for rapid communication must present new findings of sufficient importance to justify their accelerated appearance.
Double-spaced manuscripts cannot exceed 7 pages, including figures, tables and references; longer manuscripts will be returned.
Rapid communications are reviewed by two members of the Editorial Board. As a rule, they are either accepted or rejected; only minor revision is allowed. Once accepted, they are published within 2 months of acceptance. Proofs are sent to the Editor-in-Chief and to the authors.
Arrangement
Title page: The first page of each paper should carry the title, the authors?full first and last names, and the name of the institute or department where the authors conducted their research work. In addition, the following should be put on the title page: 1. A short title for use as a running head. 2. A list of 3? key words for indexing purposes. 3. The name and complete mailing address as well as phone and fax numbers of the individual to whom correspondence, galley proofs, and requests for reprints should be addressed.
Abstract: Each paper must have a short abstract describing procedures, observations and conclusions, which will appear at the beginning of the article. Abstracts should not exceed 1,800 characters.
Footnotes: Avoid footnotes if at all possible. When essential, they should be numbered consecutively and typed at the foot of the appropriate page.
Acknowledgements: Including, where relevant, credit to the sources of grant support.
Tables and illustrations: Tables (numbered in Arabic numerals) should be prepared on separate sheets, and each should have a suitable heading. Illustrations should be numbered in Arabic numerals and legends for the figures should be submitted on a separate page. For the reproduction of illustrations, only good drawings and original photographs can be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 181 x 223 mm) or provide crop marks. On the back of each illustration, indicate its number, the author's name, and top with a soft pencil. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1200 dpi.
Color Illustrations
Up to 6 color illustrations per page can now be integrated with the text at the special price of CHF 660.?/ USD 545.00 per page. Color illustrations are reproduced at the author's expense.
References
In the text identify references by Arabic numerals [in square brackets]. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of all the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309?15.)
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
(a) Papers published in periodicals: Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191?95.
(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
(d) Edited books: Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18?6. Papers that have been submitted to a journal but are not yet accepted should not be listed in the bibliography, but the data in them can be referred to in the text as unpublished observations. If details of methods are only available in papers that are in press. copies of the papers should be included with the manuscript submitted to Neuroendocrinology, so that the editorial referees can have adequate information to judge the manuscript.
Galley Proofs
Unless indicated otherwise, galley proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in galley proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.
Reprints
Order forms and a price list are sent with the galley proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
Editorial Board
Editor-in-Chief
C. Kordon, Paris
Editors
A. Enjalbert, Marseille
P.A. Kelly, Paris
R. Weiner, San Francisco, Calif.
Editorial Board
T. Bartness, Atlanta, Ga.
K. Catt, Bethesda, Md.
S.L. Dickson, Cambridge
J. Drouin, Montreal
R.C. Gaillard, Lausanne
A. Herbison, Dunedin
T. Hökfelt, Stockholm
D. Jez¨®va, Bratislava
J.Z. Kiss, Geneva
J. Levine, Evanston, Ill.
C. Llorens-Cortes, Paris
J.P. Loeffler, Strasbourg
G. Martinez de la Escalera, Quer¨¦taro
Z. Naor, Tel Aviv
S.R. Ojeda, Beaverton, Oreg.
M. Palkovits, Budapest
D.W. Pfaff, New York, N.Y.
J. Reul, Bristol
J.L. Roberts, San Antonio, Tex.
I. Robinson, London
W. Schlegel, Geneva
A.J. Silverman, New York, N.Y.
E. Spinedi, La Plata
R. Steiner, Seattle, Wash.
W. Vale, La Jolla, Calif.
H. Watanobe, Otawara
M. Wierman, Denver, Colo.
S. Wray, Bethesda, Md.
Only original papers written in English will be considered. Manuscripts should be sent to:
Dr. Claude Kordon
Institut de Recherches Necker
156 rue de Vaugirard
F 5015 Paris (France)
|
